PYLMARKER

Serial Number 88647029
606

Registration Progress

Application Filed
Oct 8, 2019
Under Examination
Apr 21, 2020
Approved for Publication
Feb 25, 2020
Published for Opposition
Feb 25, 2020
Registered

Trademark Image

PYLMARKER

Basic Information

Serial Number
88647029
Filing Date
October 8, 2019
Published for Opposition
February 25, 2020
Abandonment Date
May 22, 2023
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
May 22, 2023
Classes
005 042 044

Rights Holder

Progenics Pharmaceuticals, Inc.

03
Address
47th Floor Suite J
One World Trade Center
New York, NY 10007

Ownership History

Progenics Pharmaceuticals, Inc.

Original Applicant
03
New York, NY

Progenics Pharmaceuticals, Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Phi Lan M. Tinsley

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

42 events
Date Code Type Description Documents
May 22, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
May 22, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Feb 21, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 30, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 29, 2022 EX5G S SOU EXTENSION 5 GRANTED Loading...
Sep 28, 2022 EXT5 S SOU EXTENSION 5 FILED Loading...
Sep 28, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 30, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 28, 2022 EXT4 S SOU EXTENSION 4 FILED Loading...
Mar 28, 2022 EX4G S SOU EXTENSION 4 GRANTED Loading...
Mar 28, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 22, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 20, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
Sep 20, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
Sep 20, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 27, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 26, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 26, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 9, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 9, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 20, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 16, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 16, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Oct 16, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 16, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 16, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 16, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Oct 16, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 16, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 21, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 25, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 25, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 5, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 17, 2020 ALIE A ASSIGNED TO LIE Loading...
Jan 14, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jan 14, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jan 14, 2020 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jan 14, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 14, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 13, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 15, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 11, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Radiopharmaceutical imaging and detection agents for detection, diagnosing and monitoring cancer; pharmaceutical preparations for the detection, diagnosis, prevention, treatment and monitoring of cancer
Class 042
Scientific research and development in the nature of research, development and preparation of pharmaceutical drugs and imaging agents for medical use; Providing temporary use of non-downloadable medical imaging software for the identification, quantification, diagnosis, prevention, treatment and monitoring of cancer
Class 044
Providing medical testing services and information in the field of cancer diagnosis, treatment and prevention; Web-based medical testing for identification, quantification, diagnostic or treatment purposes in the field of cancer; providing medical information in the field of cancer identification, diagnosis, treatment and prevention; medical imaging services

Classification

International Classes
005 042 044